SEC
|
Baroldi Joseph
|
EVP, Chief Business Officer
|
|
-33K
|
$59.34
|
-$1.95M
|
|
SEC
|
BENNETT C FRANK
|
EVP, Chief Scientific Officer
|
|
-39K
|
$59.14
|
-$2.30M
|
|
SEC
|
Devers Shannon L.
|
EVP, Chief Human Resources Ofc
|
|
-3.2K
|
$61.02
|
-$192.95K
|
|
SEC
|
KLEIN JOSEPH III
|
N/A
|
|
-56K
|
$60.00
|
-$3.36M
|
|
SEC
|
LOSCALZO JOSEPH
|
N/A
|
|
-16K
|
$60.15
|
-$962.40K
|
|
SEC
|
Monia Brett P
|
Chief Executive Officer
|
|
-204K
|
$60.32
|
-$12.29M
|
|
SEC
|
O'NEIL PATRICK R.
|
EVP CLO & General Counsel
|
|
-90K
|
$60.03
|
-$5.40M
|
|
SEC
|
Schneider Eugene
|
EVP, Chf Clinical Develop Ofcr
|
|
-20K
|
$60.81
|
-$1.20M
|
|
SEC
|
WENDER JOSEPH H
|
N/A
|
|
-56K
|
$57.58
|
-$3.22M
|
|
SEC
|
Geary Richard S
|
EVP, Chief Development Officer
|
|
-10K
|
$50.37
|
-$503.70K
|
|
SEC
|
PARSHALL B LYNNE
|
N/A
|
|
-20K
|
$50.91
|
-$1.02M
|
|
SEC
|
Swayze Eric
|
EVP Research
|
|
-11K
|
$49.67
|
-$552.83K
|
|
SEC
|
Diaz Allene M.
|
N/A
|
|
-1.4K
|
$42.53
|
-$60.69K
|
|
SEC
|
BENNETT C FRANK
|
EVP, Chief Scientific Officer
|
|
-10K
|
$43.98
|
-$439.80K
|
|
SEC
|
PARSHALL B LYNNE
|
N/A
|
|
-5K
|
$41.93
|
-$209.65K
|
|
SEC
|
Geary Richard S
|
EVP, Chief Development Officer
|
|
-10K
|
$42.86
|
-$428.60K
|
|
SEC
|
Schneider Eugene
|
EVP, Chf Clinical Develop Ofcr
|
|
-9.5K
|
$42.80
|
-$408.70K
|
|
SEC
|
Monia Brett P
|
Chief Executive Officer
|
|
-2.4K
|
$45.00
|
-$109.44K
|
|
SEC
|
Monia Brett P
|
Chief Executive Officer
|
|
-1.2K
|
$41.74
|
-$48.42K
|
|
SEC
|
Hayden Michael R
|
N/A
|
|
+15K
|
$31.86
|
+$477.90K
|
|
SEC
|
Baroldi Joseph
|
EVP, Chief Business Officer
|
|
-3.9K
|
$28.40
|
-$111.56K
|
|
SEC
|
Birchler Brian
|
EVP, Corp and Development Ops
|
|
-680
|
$28.37
|
-$19.29K
|
|
SEC
|
Jenne Kyle
|
EVP, Chf GL Pdt Str Ofcr
|
|
-3K
|
$28.36
|
-$85.53K
|
|
SEC
|
Monia Brett P
|
Chief Executive Officer
|
|
-140
|
$32.32
|
-$4.52K
|
|
SEC
|
O'NEIL PATRICK R.
|
EVP CLO & General Counsel
|
|
-1.2K
|
$32.35
|
-$39.05K
|
|
SEC
|
Monia Brett P
|
Chief Executive Officer
|
|
-39K
|
$31.65
|
-$1.23M
|
|
SEC
|
O'NEIL PATRICK R.
|
EVP CLO & General Counsel
|
|
-6.2K
|
$31.62
|
-$194.94K
|
|
SEC
|
BENNETT C FRANK
|
EVP, Chief Scientific Officer
|
|
-1.3K
|
$32.46
|
-$43.07K
|
|
SEC
|
Geary Richard S
|
EVP, Chief Development Officer
|
|
-1.4K
|
$32.40
|
-$45.55K
|
|
SEC
|
HOUGEN ELIZABETH L
|
EVP, Finance & CFO
|
|
-1.5K
|
$32.44
|
-$49.41K
|
|
SEC
|
Monia Brett P
|
Chief Executive Officer
|
|
-13K
|
$32.45
|
-$429.70K
|
|
SEC
|
O'NEIL PATRICK R.
|
EVP CLO & General Counsel
|
|
-1.4K
|
$32.49
|
-$45.68K
|
|
SEC
|
Schneider Eugene
|
EVP, Chf Clinical Develop Ofcr
|
|
-1.5K
|
$32.20
|
-$47.78K
|
|
SEC
|
Swayze Eric
|
EVP Research
|
|
-1.4K
|
$32.31
|
-$44.17K
|
|
SEC
|
Baroldi Joseph
|
EVP, Chief Business Officer
|
|
-4.4K
|
$32.70
|
-$144.86K
|
|
SEC
|
BENNETT C FRANK
|
EVP, Chief Scientific Officer
|
|
-6.8K
|
$32.90
|
-$222.14K
|
|
SEC
|
Birchler Brian
|
EVP, Corp and Development Ops
|
|
-5.4K
|
$32.70
|
-$176.58K
|
|
SEC
|
Devers Shannon L.
|
EVP, Chief Human Resources Ofc
|
|
-4.3K
|
$32.78
|
-$139.87K
|
|
SEC
|
Geary Richard S
|
EVP, Chief Development Officer
|
|
-7.1K
|
$32.86
|
-$232.39K
|
|
SEC
|
HOUGEN ELIZABETH L
|
EVP, Finance & CFO
|
|
-8.9K
|
$32.81
|
-$291.02K
|
|
SEC
|
Monia Brett P
|
Chief Executive Officer
|
|
-33K
|
$32.63
|
-$1.09M
|
|
SEC
|
O'NEIL PATRICK R.
|
EVP CLO & General Counsel
|
|
-7.4K
|
$32.83
|
-$241.63K
|
|
SEC
|
Schneider Eugene
|
EVP, Chf Clinical Develop Ofcr
|
|
-6.5K
|
$32.79
|
-$213.89K
|
|
SEC
|
Swayze Eric
|
EVP Research
|
|
-7.2K
|
$32.84
|
-$235.66K
|
|
SEC
|
Hayden Michael R
|
N/A
|
|
+5K
|
$36.22
|
+$181.10K
|
|
SEC
|
LOSCALZO JOSEPH
|
N/A
|
|
-14K
|
$37.86
|
-$511.41K
|
|
SEC
|
Monia Brett P
|
Chief Executive Officer
|
|
-6.6K
|
$38.05
|
-$252.27K
|
|
SEC
|
Swayze Eric
|
EVP Research
|
|
-1.2K
|
$37.92
|
-$45.28K
|
|
SEC
|
Swayze Eric
|
EVP Research
|
|
-53
|
$38.31
|
-$2.03K
|
|
SEC
|
Geary Richard S
|
EVP, Chief Development Officer
|
|
-651
|
$49.40
|
-$32.16K
|
|
SEC
|
Geary Richard S
|
EVP, Chief Development Officer
|
|
-2.4K
|
$48.00
|
-$116.64K
|
|
SEC
|
Diaz Allene M.
|
N/A
|
|
-1.6K
|
$49.49
|
-$81.02K
|
|
SEC
|
KLEIN JOSEPH III
|
N/A
|
|
-12K
|
$50.00
|
-$600.00K
|
|
SEC
|
BERTHELSEN SPENCER R
|
N/A
|
|
-16K
|
$40.29
|
-$644.64K
|
|
SEC
|
KLEIN JOSEPH III
|
N/A
|
|
-6K
|
$42.71
|
-$256.26K
|
|
SEC
|
Baroldi Joseph
|
EVP, Chief Business Officer
|
|
-4K
|
$41.60
|
-$166.65K
|
|
SEC
|
Birchler Brian
|
EVP, Corp and Development Ops
|
|
-905
|
$41.66
|
-$37.70K
|
|
SEC
|
Monia Brett P
|
Chief Executive Officer
|
|
-387
|
$44.49
|
-$17.22K
|
|
SEC
|
BENNETT C FRANK
|
EVP, Chief Scientific Officer
|
|
-1.9K
|
$49.52
|
-$91.76K
|
|
SEC
|
Cadoret-Manier Onaiza
|
EVP, Chf GL Pdt Str & Oper Ofc
|
|
-2.1K
|
$49.60
|
-$105.40K
|
|
SEC
|
Geary Richard S
|
EVP, Chief Development Officer
|
|
-2K
|
$50.04
|
-$98.13K
|
|
SEC
|
HOUGEN ELIZABETH L
|
EVP, Finance & CFO
|
|
-2.1K
|
$49.54
|
-$105.27K
|
|
SEC
|
Monia Brett P
|
Chief Executive Officer
|
|
-24K
|
$49.37
|
-$1.16M
|
|
SEC
|
O'NEIL PATRICK R.
|
EVP CLO & General Counsel
|
|
-2K
|
$49.67
|
-$97.40K
|
|
SEC
|
Schneider Eugene
|
EVP, Chf Clinical Develop Ofcr
|
|
-2.1K
|
$49.59
|
-$102.70K
|
|
SEC
|
Swayze Eric
|
EVP Research
|
|
-13K
|
$51.63
|
-$654.67K
|
|
SEC
|
Monia Brett P
|
Chief Executive Officer
|
|
-2.3K
|
$51.75
|
-$118.25K
|
|
SEC
|
O'NEIL PATRICK R.
|
EVP CLO & General Counsel
|
|
-6.5K
|
$51.75
|
-$333.79K
|
|
SEC
|
Baroldi Joseph
|
EVP, Chief Business Officer
|
|
-2K
|
$50.42
|
-$102.05K
|
|
SEC
|
BENNETT C FRANK
|
EVP, Chief Scientific Officer
|
|
-6.7K
|
$50.42
|
-$340.08K
|
|
SEC
|
Birchler Brian
|
EVP, Corp and Development Ops
|
|
-4.5K
|
$50.42
|
-$226.74K
|
|
SEC
|
Cadoret-Manier Onaiza
|
EVP, Chf GL Pdt Str & Oper Ofc
|
|
-5.6K
|
$50.42
|
-$280.54K
|
|
SEC
|
Geary Richard S
|
EVP, Chief Development Officer
|
|
-7.3K
|
$50.42
|
-$369.98K
|
|
SEC
|
HOUGEN ELIZABETH L
|
EVP, Finance & CFO
|
|
-8.7K
|
$50.42
|
-$437.80K
|
|
SEC
|
Monia Brett P
|
Chief Executive Officer
|
|
-32K
|
$50.42
|
-$1.62M
|
|
SEC
|
O'NEIL PATRICK R.
|
EVP CLO & General Counsel
|
|
-7.7K
|
$50.42
|
-$390.45K
|
|
SEC
|
Schneider Eugene
|
EVP, Chf Clinical Develop Ofcr
|
|
-5.5K
|
$50.42
|
-$276.40K
|
|
SEC
|
Swayze Eric
|
EVP Research
|
|
-6.3K
|
$50.42
|
-$317.90K
|
|
SEC
|
Schneider Eugene
|
EVP, Chf Clinical Develop Ofcr
|
|
-8K
|
$53.50
|
-$428.00K
|
|
SEC
|
PARSHALL B LYNNE
|
N/A
|
|
-118K
|
$50.48
|
-$5.94M
|
|
SEC
|
Swayze Eric
|
EVP Research
|
|
-27K
|
$50.19
|
-$1.36M
|
|
SEC
|
O'NEIL PATRICK R.
|
EVP CLO & General Counsel
|
|
-21K
|
$51.46
|
-$1.07M
|
|
SEC
|
Schneider Eugene
|
EVP, Chf Clinical Develop Ofcr
|
|
-25K
|
$51.46
|
-$1.29M
|
|
SEC
|
BENNETT C FRANK
|
EVP, Chief Scientific Officer
|
|
-23K
|
$49.39
|
-$1.12M
|
|
SEC
|
Geary Richard S
|
EVP, Chief Development Officer
|
|
-11K
|
$49.50
|
-$525.29K
|
|
SEC
|
Monia Brett P
|
Chief Executive Officer
|
|
-24K
|
$49.38
|
-$1.19M
|
|
SEC
|
BENNETT C FRANK
|
EVP, Chief Scientific Officer
|
|
-23K
|
$49.58
|
-$1.12M
|
|
SEC
|
Geary Richard S
|
EVP, Chief Development Officer
|
|
-11K
|
$49.58
|
-$526.19K
|
|
SEC
|
Monia Brett P
|
Chief Executive Officer
|
|
-24K
|
$49.58
|
-$1.19M
|
|
SEC
|
KLEIN JOSEPH III
|
N/A
|
|
-2K
|
$50.00
|
-$100.00K
|
|
SEC
|
Swayze Eric
|
EVP Research
|
|
-52
|
$47.95
|
-$2.49K
|
|
SEC
|
Monia Brett P
|
Chief Executive Officer
|
|
-3.8K
|
$46.00
|
-$173.42K
|
|
SEC
|
BENNETT C FRANK
|
EVP, Chief Scientific Officer
|
|
-4.5K
|
$46.50
|
-$207.39K
|
|
SEC
|
KLEIN JOSEPH III
|
N/A
|
|
-2K
|
$45.13
|
-$90.26K
|
|
SEC
|
PARSHALL B LYNNE
|
N/A
|
|
-10K
|
$45.13
|
-$451.30K
|
|
SEC
|
Diaz Allene M.
|
N/A
|
|
-657
|
$41.05
|
-$26.97K
|
|
SEC
|
KLEIN JOSEPH III
|
N/A
|
|
-3.6K
|
$42.00
|
-$149.31K
|
|
SEC
|
Monia Brett P
|
Chief Executive Officer
|
|
-19K
|
$42.25
|
-$787.96K
|
|
SEC
|
O'NEIL PATRICK R.
|
EVP CLO & General Counsel
|
|
-1.5K
|
$41.70
|
-$63.68K
|
|
SEC
|
Monia Brett P
|
Chief Executive Officer
|
|
-4.9K
|
$40.14
|
-$197.93K
|
|
SEC
|
Baroldi Joseph
|
EVP, Chief Business Officer
|
|
-3.9K
|
$36.50
|
-$141.62K
|
|
SEC
|
Birchler Brian
|
EVP, Corp and Development Ops
|
|
-672
|
$36.50
|
-$24.53K
|
|
SEC
|
Cadoret-Manier Onaiza
|
EVP, Chf GL Pdt Str & Oper Ofc
|
|
-2.6K
|
$36.50
|
-$94.24K
|
|
SEC
|
BENNETT C FRANK
|
EVP, Chief Scientific Officer
|
|
+1.8K
|
$13.57
|
+$24.37K
|
|
SEC
|
Cadoret-Manier Onaiza
|
EVP, Chf GL Pdt Str & Oper Ofc
|
|
+2.7K
|
$10.55
|
+$28.37K
|
|
SEC
|
Geary Richard S
|
EVP, Chief Development Officer
|
|
+1.9K
|
$13.60
|
+$25.87K
|
|
SEC
|
HOUGEN ELIZABETH L
|
EVP, Finance & CFO
|
|
+2.1K
|
$13.57
|
+$27.97K
|
|
SEC
|
Monia Brett P
|
Chief Executive Officer
|
|
+24K
|
$13.60
|
+$332.41K
|
|
SEC
|
O'NEIL PATRICK R.
|
EVP CLO & General Counsel
|
|
+1.9K
|
$13.66
|
+$25.98K
|
|
SEC
|
Schneider Eugene
|
EVP, Chf Clinical Develop Ofcr
|
|
+2.6K
|
$10.55
|
+$27.64K
|
|
SEC
|
Swayze Eric
|
EVP Research
|
|
+1.9K
|
$13.39
|
+$25.44K
|
|
SEC
|
O'NEIL PATRICK R.
|
EVP CLO & General Counsel
|
|
-9K
|
$39.56
|
-$356.04K
|
|
SEC
|
Baroldi Joseph
|
EVP, Chief Business Officer
|
|
+529
|
$11.67
|
+$6.17K
|
|
SEC
|
BENNETT C FRANK
|
EVP, Chief Scientific Officer
|
|
+12K
|
$10.28
|
+$127.87K
|
|
SEC
|
Cadoret-Manier Onaiza
|
EVP, Chf GL Pdt Str & Oper Ofc
|
|
+6.4K
|
$10.63
|
+$68.55K
|
|
SEC
|
Geary Richard S
|
EVP, Chief Development Officer
|
|
+14K
|
$10.43
|
+$147.17K
|
|
SEC
|
HOUGEN ELIZABETH L
|
EVP, Finance & CFO
|
|
+15K
|
$10.46
|
+$155.58K
|
|
SEC
|
Monia Brett P
|
Chief Executive Officer
|
|
+32K
|
$12.02
|
+$387.06K
|
|
SEC
|
O'NEIL PATRICK R.
|
EVP CLO & General Counsel
|
|
+14K
|
$10.42
|
+$146.24K
|
|
SEC
|
Schneider Eugene
|
EVP, Chf Clinical Develop Ofcr
|
|
+8.3K
|
$10.57
|
+$87.67K
|
|
SEC
|
Swayze Eric
|
EVP Research
|
|
+10K
|
$10.45
|
+$106.06K
|
|
SEC
|
KLEIN JOSEPH III
|
N/A
|
|
-2K
|
$40.00
|
-$80.00K
|
|
SEC
|
Schneider Eugene
|
EVP, Chf Clinical Develop Ofcr
|
|
+272
|
$11.96
|
+$3.25K
|
|
SEC
|
Swayze Eric
|
EVP Research
|
|
-460
|
$44.55
|
-$20.49K
|
|
SEC
|
BENNETT C FRANK
|
EVP, Chief Scientific Officer
|
|
+183
|
$28.97
|
+$5.30K
|
|
SEC
|
HOUGEN ELIZABETH L
|
EVP, Finance & CFO
|
|
+202
|
$28.97
|
+$5.85K
|
|
SEC
|
O'NEIL PATRICK R.
|
EVP CLO & General Counsel
|
|
+108
|
$28.97
|
+$3.13K
|
|
SEC
|
Swayze Eric
|
EVP Research
|
|
-1
|
$45.20
|
-$45.20
|
|
SEC
|
KLEIN JOSEPH III
|
N/A
|
|
+6.7K
|
$5.46
|
+$36.39K
|
|
SEC
|
MUTO FREDERICK T
|
N/A
|
|
+11K
|
$12.94
|
+$145.58K
|
|
SEC
|
BERTHELSEN SPENCER R
|
N/A
|
|
+11K
|
$12.94
|
+$145.58K
|
|
SEC
|
Swayze Eric
|
EVP Research
|
|
-378
|
$44.15
|
-$16.69K
|
|
SEC
|
Cadoret-Manier Onaiza
|
EVP, Chf Pdt Str & Oper Ofc
|
|
+3.7K
|
$10.54
|
+$39.07K
|
|
SEC
|
O'NEIL PATRICK R.
|
EVP CLO & General Counsel
|
|
-6.8K
|
$40.06
|
-$272.09K
|
|
SEC
|
Monia Brett P
|
Chief Executive Officer
|
|
-355
|
$37.49
|
-$13.31K
|
|
SEC
|
BENNETT C FRANK
|
EVP, Chief Scientific Officer
|
|
+346
|
$28.37
|
+$9.82K
|
|
SEC
|
Geary Richard S
|
EVP, Chief Development Officer
|
|
+621
|
$28.37
|
+$17.62K
|
|
SEC
|
HOUGEN ELIZABETH L
|
EVP, Finance & CFO
|
|
+384
|
$28.37
|
+$10.89K
|
|
SEC
|
Monia Brett P
|
Chief Executive Officer
|
|
+621
|
$28.37
|
+$17.62K
|
|
SEC
|
O'NEIL PATRICK R.
|
EVP CLO & General Counsel
|
|
+735
|
$28.37
|
+$20.85K
|
|
SEC
|
Swayze Eric
|
EVP Research
|
|
+621
|
$28.37
|
+$17.62K
|
|
SEC
|
Monia Brett P
|
Chief Executive Officer
|
|
+8.2K
|
$10.42
|
+$85.09K
|
|
SEC
|
BENNETT C FRANK
|
EVP, Chief Scientific Officer
|
|
+12K
|
$7.92
|
+$95.96K
|
|
SEC
|
Cadoret-Manier Onaiza
|
EVP, Chf Corp Dev and Cml Offc
|
|
+3.8K
|
$8.30
|
+$31.14K
|
|
SEC
|
Geary Richard S
|
EVP, Chief Development Officer
|
|
+14K
|
$7.90
|
+$108.91K
|
|
SEC
|
HOUGEN ELIZABETH L
|
EVP, Finance & CFO
|
|
+14K
|
$7.89
|
+$112.21K
|
|
SEC
|
Monia Brett P
|
Chief Executive Officer
|
|
+30K
|
$8.58
|
+$255.35K
|
|
SEC
|
O'NEIL PATRICK R.
|
EVP CLO & General Counsel
|
|
+14K
|
$7.90
|
+$107.32K
|
|
SEC
|
PARSHALL B LYNNE
|
N/A
|
|
+4.1K
|
$6.72
|
+$27.57K
|
|
SEC
|
Schneider Eugene
|
EVP, Chf Clinical Develop Offc
|
|
+6.6K
|
$8.08
|
+$53.21K
|
|
SEC
|
Swayze Eric
|
EVP Research
|
|
+8.8K
|
$8.00
|
+$70.52K
|
|
SEC
|
Schneider Eugene
|
EVP, Chf Clinical Develop Offc
|
|
+272
|
$9.06
|
+$2.46K
|
|
SEC
|
BENNETT C FRANK
|
EVP & Chief Scientific Officer
|
|
+151
|
$33.80
|
+$5.10K
|
|
SEC
|
Cadoret-Manier Onaiza
|
Chief Corp Dev and Cml Officer
|
|
+431
|
$33.80
|
+$14.57K
|
|
SEC
|
Geary Richard S
|
EVP, Chief Development Offc
|
|
+46
|
$33.80
|
+$1.55K
|
|
SEC
|
HOUGEN ELIZABETH L
|
EVP, Finance & CFO
|
|
+166
|
$33.80
|
+$5.61K
|
|
SEC
|
Monia Brett P
|
Chief Executive Officer
|
|
+355
|
$33.80
|
+$12.00K
|
|
SEC
|
O'NEIL PATRICK R.
|
EVP Legal & General Counsel
|
|
+309
|
$33.80
|
+$10.44K
|
|
SEC
|
KLEIN JOSEPH III
|
N/A
|
|
+4.3K
|
$11.77
|
+$50.99K
|
|
SEC
|
Cadoret-Manier Onaiza
|
Chief Corp Dev and Cml Officer
|
|
+3.7K
|
$10.54
|
+$39.07K
|
|
SEC
|
Monia Brett P
|
Chief Executive Officer
|
|
+11
|
$49.30
|
+$542.30
|
|
SEC
|
BENNETT C FRANK
|
Chief Scientific Officer
|
|
+112
|
$44.54
|
+$4.99K
|
|
SEC
|
Cadoret-Manier Onaiza
|
Chief Corp Dev and Cml Officer
|
|
+492
|
$44.54
|
+$21.91K
|
|
SEC
|
Geary Richard S
|
EVP, Chief Development Offc
|
|
+414
|
$44.54
|
+$18.44K
|
|
SEC
|
HOUGEN ELIZABETH L
|
EVP, Finance & CFO
|
|
+116
|
$44.54
|
+$5.17K
|
|
SEC
|
O'NEIL PATRICK R.
|
EVP & General Counsel
|
|
+197
|
$44.54
|
+$8.77K
|
|
SEC
|
Swayze Eric
|
EVP, Research
|
|
+460
|
$44.54
|
+$20.49K
|
|
SEC
|
Monia Brett P
|
Chief Executive Officer
|
|
+1.3K
|
$20.12
|
+$26.72K
|
|
SEC
|
CROOKE STANLEY T
|
Exec Chairman of the Board
|
|
-28K
|
$63.74
|
-$1.81M
|
|
SEC
|
O'NEIL PATRICK R.
|
EVP & General Counsel
|
|
-5.3K
|
$63.50
|
-$338.07K
|
|
SEC
|
CROOKE STANLEY T
|
Exec Chairman of the Board
|
|
-75K
|
$61.45
|
-$4.61M
|
|
SEC
|
BENNETT C FRANK
|
Chief Scientific Officer
|
|
+10K
|
$16.01
|
+$160.61K
|
|
SEC
|
CROOKE STANLEY T
|
Exec Chairman of the Board
|
|
+60K
|
$17.33
|
+$1.03M
|
|
SEC
|
Geary Richard S
|
EVP, Chief Development Offc
|
|
+11K
|
$16.34
|
+$183.01K
|
|
SEC
|
HOUGEN ELIZABETH L
|
EVP, Finance & CFO
|
|
+11K
|
$16.22
|
+$178.03K
|
|
SEC
|
Monia Brett P
|
Chief Executive Officer
|
|
+20K
|
$18.39
|
+$365.89K
|
|
SEC
|
O'NEIL PATRICK R.
|
EVP & General Counsel
|
|
+11K
|
$16.05
|
+$170.90K
|
|
SEC
|
PARSHALL B LYNNE
|
N/A
|
|
+7.9K
|
$12.54
|
+$99.24K
|
|
SEC
|
Schneider Eugene
|
EVP, Chf Clinical Develop Offc
|
|
+4.8K
|
$16.30
|
+$78.00K
|
|
SEC
|
Swayze Eric
|
EVP, Research
|
|
+5.7K
|
$16.21
|
+$92.85K
|
|
SEC
|
Geary Richard S
|
EVP, Chief Development Offc
|
|
-141
|
$59.50
|
-$8.39K
|
|
SEC
|
Swayze Eric
|
EVP, Research
|
|
-195
|
$55.99
|
-$10.92K
|
|
SEC
|
PARSHALL B LYNNE
|
N/A
|
|
-10K
|
$60.00
|
-$600.00K
|
|
SEC
|
CROOKE STANLEY T
|
Exec Chairman of the Board
|
|
-40K
|
$49.80
|
-$2.01M
|
|
SEC
|
CROOKE STANLEY T
|
Exec Chairman of the Board
|
|
-11K
|
$51.67
|
-$568.37K
|
|
SEC
|
BENNETT C FRANK
|
Chief Scientific Officer
|
|
-15K
|
$46.77
|
-$701.55K
|
|
SEC
|
KLEIN JOSEPH III
|
N/A
|
|
-2.9K
|
$46.86
|
-$135.38K
|
|
SEC
|
CROOKE STANLEY T
|
Exec Chairman of the Board
|
|
-52K
|
$50.40
|
-$2.62M
|
|
SEC
|
WENDER JOSEPH H
|
N/A
|
|
+23K
|
$20.71
|
+$465.98K
|
|
SEC
|
Monia Brett P
|
Chief Executive Officer
|
|
-78
|
$49.73
|
-$3.88K
|
|
SEC
|
BENNETT C FRANK
|
Chief Scientific Officer
|
|
+112
|
$44.46
|
+$4.98K
|
|
SEC
|
Geary Richard S
|
EVP, Development
|
|
+1
|
$44.46
|
+$44.46
|
|
SEC
|
HOUGEN ELIZABETH L
|
EVP, Finance & CFO
|
|
+121
|
$44.46
|
+$5.38K
|
|
SEC
|
O'NEIL PATRICK R.
|
EVP & General Counsel
|
|
+169
|
$44.46
|
+$7.51K
|
|
SEC
|
Swayze Eric
|
EVP, Research
|
|
+1
|
$44.46
|
+$44.46
|
|
SEC
|
MUTO FREDERICK T
|
N/A
|
|
+15K
|
$9.22
|
+$138.30K
|
|
SEC
|
CROOKE STANLEY T
|
Exec Chairman of the Board
|
|
-15K
|
$59.67
|
-$889.92K
|
|
SEC
|
CROOKE STANLEY T
|
Exec Chairman of the Board
|
|
-27K
|
$58.08
|
-$1.57M
|
|
SEC
|
CROOKE STANLEY T
|
Exec Chairman of the Board
|
|
-16K
|
$47.00
|
-$752.00K
|
|
SEC
|
CROOKE STANLEY T
|
Exec Chairman of the Board
|
|
-16K
|
$45.16
|
-$722.56K
|
|
SEC
|
CROOKE STANLEY T
|
Exec Chairman of the Board
|
|
-20K
|
$44.75
|
-$912.45K
|
|
SEC
|
BENNETT C FRANK
|
Chief Scientific Officer
|
|
+169
|
$43.16
|
+$7.29K
|
|
SEC
|
Geary Richard S
|
SVP, Development
|
|
+378
|
$43.16
|
+$16.31K
|
|
SEC
|
HOUGEN ELIZABETH L
|
SVP, Finance & CFO
|
|
+147
|
$43.16
|
+$6.34K
|
|
SEC
|
Monia Brett P
|
Chief Executive Officer
|
|
+314
|
$43.16
|
+$13.55K
|
|
SEC
|
O'NEIL PATRICK R.
|
SVP & General Counsel
|
|
+289
|
$43.16
|
+$12.47K
|
|
SEC
|
Swayze Eric
|
SVP, Research
|
|
+378
|
$43.16
|
+$16.31K
|
|
SEC
|
O'NEIL PATRICK R.
|
SVP & General Counsel
|
|
-3.9K
|
$59.60
|
-$231.37K
|
|
SEC
|
BENNETT C FRANK
|
Chief Scientific Officer
|
|
+7.5K
|
$16.27
|
+$122.82K
|
|
SEC
|
CROOKE STANLEY T
|
Executive Chairman of Board
|
|
+24K
|
$18.76
|
+$456.81K
|
|
SEC
|
Geary Richard S
|
SVP, Development
|
|
+8.5K
|
$16.23
|
+$137.71K
|
|
SEC
|
HOUGEN ELIZABETH L
|
SVP, Finance & CFO
|
|
+7.8K
|
$16.26
|
+$126.29K
|
|
SEC
|
Monia Brett P
|
Chief Executive Officer
|
|
+12K
|
$17.08
|
+$211.07K
|
|
SEC
|
O'NEIL PATRICK R.
|
SVP, Legal & General Counsel
|
|
+7.8K
|
$16.26
|
+$126.31K
|
|
SEC
|
PARSHALL B LYNNE
|
N/A
|
|
+11K
|
$12.73
|
+$142.97K
|
|
SEC
|
Swayze Eric
|
SVP, Research
|
|
+4.2K
|
$16.53
|
+$68.68K
|
|
SEC
|
Monia Brett P
|
Chief Executive Officer
|
|
-173
|
$60.25
|
-$10.42K
|
|
SEC
|
HOUGEN ELIZABETH L
|
SVP, Finance & CFO
|
|
+4.4K
|
$29.55
|
+$130.17K
|
|
SEC
|
KLEIN JOSEPH III
|
N/A
|
|
-812
|
$62.90
|
-$51.07K
|
|
SEC
|
KLEIN JOSEPH III
|
N/A
|
|
-2K
|
$60.00
|
-$120.00K
|
|
SEC
|
Monia Brett P
|
COO & SVP, Translational Med
|
|
-5.8K
|
$60.01
|
-$346.62K
|
|
SEC
|
Monia Brett P
|
Chief Operating Officer
|
|
-37
|
$57.05
|
-$2.11K
|
|
SEC
|
BENNETT C FRANK
|
SVP, Antisense Research
|
|
+118
|
$45.70
|
+$5.39K
|
|
SEC
|
Geary Richard S
|
SVP, Development
|
|
+141
|
$45.70
|
+$6.44K
|
|
SEC
|
HOUGEN ELIZABETH L
|
SVP Finance & CFO
|
|
+105
|
$45.70
|
+$4.80K
|
|
SEC
|
McDevitt Damien
|
Chief Business Officer
|
|
+256
|
$45.70
|
+$11.70K
|
|
SEC
|
O'NEIL PATRICK R.
|
SVP Legal & General Counsel
|
|
+161
|
$45.70
|
+$7.36K
|
|
SEC
|
O'NEIL PATRICK R.
|
SVP Legal & General Counsel
|
|
-3K
|
$71.31
|
-$213.93K
|
|
SEC
|
WENDER JOSEPH H
|
N/A
|
|
-10K
|
$79.63
|
-$796.30K
|
|
SEC
|
Geary Richard S
|
SVP, Development
|
|
-999
|
$60.00
|
-$59.94K
|
|
SEC
|
BENNETT C FRANK
|
SVP, Antisense Research
|
|
+5K
|
$15.43
|
+$77.21K
|
|
SEC
|
CROOKE STANLEY T
|
Chairman and CEO
|
|
+19K
|
$17.05
|
+$329.15K
|
|
SEC
|
Geary Richard S
|
SVP, Development
|
|
+5.2K
|
$15.41
|
+$79.78K
|
|
SEC
|
HOUGEN ELIZABETH L
|
SVP Finance & CFO
|
|
+5K
|
$15.43
|
+$77.91K
|
|
SEC
|
Monia Brett P
|
Chief Operating Officer
|
|
+6.4K
|
$15.33
|
+$98.63K
|
|
SEC
|
O'NEIL PATRICK R.
|
SVP Legal & General Counsel
|
|
+5.1K
|
$15.09
|
+$76.79K
|
|
SEC
|
PARSHALL B LYNNE
|
N/A
|
|
+14K
|
$13.38
|
+$193.97K
|
|
SEC
|
O'NEIL PATRICK R.
|
SVP Legal & General Counsel
|
|
+66
|
$45.94
|
+$3.03K
|
|
SEC
|
Monia Brett P
|
Chief Operating Officer
|
|
-4
|
$45.05
|
-$180.20
|
|
SEC
|
BENNETT C FRANK
|
SVP, Antisense Research
|
|
+128
|
$36.45
|
+$4.67K
|
|
SEC
|
Geary Richard S
|
SVP, Development
|
|
+407
|
$36.45
|
+$14.84K
|
|
SEC
|
HOUGEN ELIZABETH L
|
SVP Finance & CFO
|
|
+127
|
$36.45
|
+$4.63K
|
|
SEC
|
Monia Brett P
|
Chief Operating Officer
|
|
-156
|
$47.03
|
-$7.34K
|
|
SEC
|
WENDER JOSEPH H
|
N/A
|
|
+30K
|
$9.26
|
+$277.80K
|
|
SEC
|
BENNETT C FRANK
|
SVP, Antisense Research
|
|
+282
|
$35.42
|
+$9.99K
|
|
SEC
|
Geary Richard S
|
SVP, Development
|
|
+177
|
$35.42
|
+$6.27K
|
|
SEC
|
HOUGEN ELIZABETH L
|
SVP Finance & CFO
|
|
+274
|
$35.42
|
+$9.71K
|
|
SEC
|
Monia Brett P
|
Chief Operating Officer
|
|
+214
|
$35.42
|
+$7.58K
|
|
SEC
|
O'NEIL PATRICK R.
|
SVP Legal & General Counsel
|
|
+66
|
$35.42
|
+$2.34K
|
|
SEC
|
BENNETT C FRANK
|
SVP, Antisense Research
|
|
+4K
|
$14.91
|
+$59.15K
|
|
SEC
|
Boyce Sarah
|
Chief Business Officer
|
|
+3.2K
|
$15.03
|
+$47.66K
|
|
SEC
|
Geary Richard S
|
SVP, Development
|
|
+4K
|
$14.91
|
+$59.77K
|
|
SEC
|
HOUGEN ELIZABETH L
|
SVP, Finance & CFO
|
|
+4K
|
$14.91
|
+$59.76K
|
|
SEC
|
Monia Brett P
|
COO
|
|
+4.2K
|
$14.89
|
+$62.00K
|
|
SEC
|
O'NEIL PATRICK R.
|
SVP, Legal & General Counsel
|
|
+4K
|
$14.91
|
+$59.13K
|
|
SEC
|
PARSHALL B LYNNE
|
N/A
|
|
+12K
|
$12.74
|
+$157.38K
|
|
SEC
|
CROOKE STANLEY T
|
Chairman and CEO
|
|
+15K
|
$17.89
|
+$264.50K
|
|
SEC
|
Monia Brett P
|
SVP, Antisense Drug Discovery
|
|
-7
|
$46.46
|
-$325.22
|
|
SEC
|
BENNETT C FRANK
|
SVP, Antisense Research
|
|
+106
|
$42.76
|
+$4.53K
|
|
SEC
|
Boyce Sarah
|
Chief Business Officer
|
|
+491
|
$42.76
|
+$21.00K
|
|
SEC
|
Geary Richard S
|
SVP, Development
|
|
+320
|
$42.76
|
+$13.68K
|
|
SEC
|
HOUGEN ELIZABETH L
|
SVP, Finance & CFO
|
|
+100
|
$42.76
|
+$4.28K
|
|
SEC
|
O'NEIL PATRICK R.
|
SVP, Legal & General Counsel
|
|
+53
|
$42.76
|
+$2.27K
|
|
SEC
|
PARSHALL B LYNNE
|
COO
|
|
+86
|
$42.76
|
+$3.68K
|
|
SEC
|
KLEIN JOSEPH III
|
N/A
|
|
+2.8K
|
$30.22
|
+$84.98K
|
|
SEC
|
KLEIN JOSEPH III
|
N/A
|
|
-3K
|
$55.39
|
-$166.17K
|
|
SEC
|
Geary Richard S
|
SVP, Development
|
|
-807
|
$35.06
|
-$28.29K
|
|
SEC
|
Monia Brett P
|
SVP, Antisense Drug Discovery
|
|
-146
|
$47.66
|
-$6.96K
|
|
SEC
|
BENNETT C FRANK
|
SVP, Antisense Research
|
|
+253
|
$40.66
|
+$10.29K
|
|
SEC
|
Boyce Sarah
|
Chief Business Officer
|
|
+17
|
$40.66
|
+$691.22
|
|
SEC
|
Geary Richard S
|
SVP, Development
|
|
+196
|
$40.66
|
+$7.97K
|
|
SEC
|
HOUGEN ELIZABETH L
|
SVP, Finance & CFO
|
|
+104
|
$40.66
|
+$4.23K
|
|
SEC
|
O'NEIL PATRICK R.
|
SVP, Legal & General Counsel
|
|
+134
|
$40.66
|
+$5.45K
|
|
SEC
|
PARSHALL B LYNNE
|
COO
|
|
+90
|
$40.66
|
+$3.66K
|
|
SEC
|
O'NEIL PATRICK R.
|
SVP, Legal & General Counsel
|
|
-150
|
$32.26
|
-$4.84K
|
|
SEC
|
O'NEIL PATRICK R.
|
SVP, Legal & General Counsel
|
|
-1K
|
$40.07
|
-$40.07K
|
|
SEC
|
O'NEIL PATRICK R.
|
SVP, Legal & General Counsel
|
|
-1K
|
$39.67
|
-$39.67K
|
|
SEC
|
O'NEIL PATRICK R.
|
SVP, Legal & General Counsel
|
|
-1K
|
$37.30
|
-$37.30K
|
|
SEC
|
BENNETT C FRANK
|
SVP, Antisense Research
|
|
+3.8K
|
$13.01
|
+$49.10K
|
|
SEC
|
Boyce Sarah
|
Chief Business Officer
|
|
+2.1K
|
$13.01
|
+$27.61K
|
|
SEC
|
CROOKE STANLEY T
|
Chairman and CEO
|
|
+14K
|
$16.13
|
+$223.84K
|
|
SEC
|
Geary Richard S
|
SVP, Development
|
|
+3.8K
|
$13.01
|
+$49.50K
|
|
SEC
|
HOUGEN ELIZABETH L
|
SVP, Finance & CFO
|
|
+3.5K
|
$13.01
|
+$46.07K
|
|
SEC
|
Monia Brett P
|
SVP, Antisense Drug Discovery
|
|
+3.9K
|
$13.01
|
+$50.74K
|
|
SEC
|
O'NEIL PATRICK R.
|
SVP, Legal & General Counsel
|
|
+3.5K
|
$13.01
|
+$45.52K
|
|
SEC
|
PARSHALL B LYNNE
|
COO
|
|
+8.8K
|
$14.41
|
+$126.62K
|
|
SEC
|
BENNETT C FRANK
|
SVP, Antisense Research
|
|
+211
|
$20.76
|
+$4.38K
|
|
SEC
|
Boyce Sarah
|
Chief Business Officer
|
|
+992
|
$20.76
|
+$20.59K
|
|
SEC
|
Geary Richard S
|
SVP, Development
|
|
+640
|
$20.76
|
+$13.29K
|
|
SEC
|
HOUGEN ELIZABETH L
|
SVP, Finance & CFO
|
|
+199
|
$20.76
|
+$4.13K
|
|
SEC
|
O'NEIL PATRICK R.
|
SVP, Legal & General Counsel
|
|
+424
|
$20.76
|
+$8.80K
|
|
SEC
|
PARSHALL B LYNNE
|
COO
|
|
+171
|
$20.76
|
+$3.55K
|
|
SEC
|
Monia Brett P
|
SVP, Antisense Drug Discovery
|
|
-130
|
$52.48
|
-$6.82K
|
|
SEC
|
PARSHALL B LYNNE
|
COO
|
|
-4K
|
$50.00
|
-$200.00K
|
|
SEC
|
HOUGEN ELIZABETH L
|
SVP, Finance & CFO
|
|
-2.5K
|
$46.05
|
-$115.13K
|
|
SEC
|
O'NEIL PATRICK R.
|
SVP, Legal & General Counsel
|
|
-350
|
$45.00
|
-$15.75K
|
|
SEC
|
PARSHALL B LYNNE
|
COO
|
|
-13K
|
$42.23
|
-$527.88K
|
|
SEC
|
HOUGEN ELIZABETH L
|
SVP, Finance & CFO
|
|
-2.5K
|
$47.50
|
-$118.75K
|
|
SEC
|
O'NEIL PATRICK R.
|
SVP, Legal & General Counsel
|
|
-1K
|
$45.00
|
-$45.00K
|
|
SEC
|
HOUGEN ELIZABETH L
|
SVP, Finance & CFO
|
|
-5K
|
$39.74
|
-$198.70K
|
|
SEC
|
CROOKE STANLEY T
|
Chairman and CEO
|
|
-33K
|
$37.72
|
-$1.24M
|
|
SEC
|
BENNETT C FRANK
|
SVP, Antisense Research
|
|
-23K
|
$37.56
|
-$856.56K
|
|
SEC
|
BENNETT C FRANK
|
SVP, Antisense Research
|
|
-5K
|
$34.00
|
-$170.00K
|
|
SEC
|
CROOKE STANLEY T
|
Chairman and CEO
|
|
-11K
|
$36.61
|
-$402.71K
|
|
SEC
|
CROOKE STANLEY T
|
Chairman and CEO
|
|
-22K
|
$36.02
|
-$792.44K
|
|
SEC
|
CROOKE STANLEY T
|
Chairman and CEO
|
|
-22K
|
$35.50
|
-$781.00K
|
|
SEC
|
PARSHALL B LYNNE
|
COO
|
|
-13K
|
$29.88
|
-$373.50K
|
|
SEC
|
MUTO FREDERICK T
|
N/A
|
|
-13K
|
$22.31
|
-$278.88K
|
|
SEC
|
CROOKE STANLEY T
|
Chairman and CEO
|
|
-11K
|
$46.13
|
-$507.43K
|
|
SEC
|
O'NEIL PATRICK R.
|
SVP, Legal & General Counsel
|
|
-1K
|
$45.00
|
-$45.00K
|
|
SEC
|
CROOKE STANLEY T
|
Chairman and CEO
|
|
-11K
|
$40.74
|
-$448.14K
|
|
SEC
|
O'NEIL PATRICK R.
|
SVP, Legal & General Counsel
|
|
-1K
|
$45.40
|
-$45.40K
|
|
SEC
|
BENNETT C FRANK
|
SVP, Antisense Research
|
|
-2.1K
|
$41.46
|
-$87.48K
|
|
SEC
|
Boyce Sarah
|
Chief Business Officer
|
|
-872
|
$41.46
|
-$36.15K
|
|
SEC
|
CROOKE STANLEY T
|
Chairman and CEO
|
|
-13K
|
$41.46
|
-$555.61K
|
|
SEC
|
Geary Richard S
|
SVP, Development
|
|
-2.2K
|
$41.46
|
-$89.64K
|
|
SEC
|
HOUGEN ELIZABETH L
|
SVP, Finance & CFO
|
|
-1.9K
|
$41.46
|
-$78.73K
|
|
SEC
|
Monia Brett P
|
SVP, Antisense Drug Discovery
|
|
-2.2K
|
$41.46
|
-$91.54K
|
|
SEC
|
O'NEIL PATRICK R.
|
SVP, Legal & General Counsel
|
|
-1.9K
|
$41.46
|
-$77.57K
|
|
SEC
|
PARSHALL B LYNNE
|
COO & Secretary
|
|
-5.2K
|
$41.46
|
-$215.26K
|
|
SEC
|
CROOKE STANLEY T
|
Chairman and CEO
|
|
-5.5K
|
$62.10
|
-$341.55K
|
|
SEC
|
CROOKE STANLEY T
|
Chairman and CEO
|
|
-11K
|
$61.05
|
-$671.55K
|
|
SEC
|
Monia Brett P
|
SVP, Antisense Drug Discovery
|
|
-127
|
$61.00
|
-$7.75K
|
|
SEC
|
O'NEIL PATRICK R.
|
SVP, Legal & General Counsel
|
|
-1K
|
$61.10
|
-$61.10K
|
|
SEC
|
PARSHALL B LYNNE
|
COO & Secretary
|
|
-809
|
$61.05
|
-$49.39K
|
|